BAWEI
837023
XI'AN WONDER
836419
Jiangsu Tiangong Technology
920068
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
CN Stock MarketDetailed Quotes
688428 InnoCare Pharma
- 20.62
- +0.71+3.57%
Market Closed May 15 15:00 CST
36.34BMarket Cap-129.69P/E (TTM)
20.83High19.91Low61.74KlotVolume20.00Open19.91Pre Close126.54MTurnover2.32%Turnover RatioLossP/E (Static)1.76BShares22.5452wk High5.39P/B5.49BFloat Cap7.2852wk Low23.89Limit Up266.28MShs Float22.54Historical High15.93Limit Down4.62%Amplitude7.28Historical Low--Dividend TTM20.50Avg Price28.33KlotAsk--Div YieldTTM100Lot Size31.79KlotBid
InnoCare Pharma Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -22.86%6.33B | -24.69%6.24B | -17.22%6.84B | -17.47%6.95B | -4.00%8.2B | -5.21%8.29B | -4.69%8.26B | 40.48%8.42B | --8.54B | 46.45%8.74B |
| Transactional financial assets | --681.19M | --759.18M | --244.19M | --350.41M | ---- | ---- | ---- | ---- | ---- | ---- |
| Notes receivable and accounts receivable | 56.06%363.57M | 27.00%351M | 65.10%303.97M | 34.12%280.68M | 77.30%232.96M | 116.22%276.38M | 44.48%184.12M | 190.25%209.27M | --131.39M | 182.34%127.82M |
| -Notes receivable | ---- | ---- | ---- | ---- | ---- | ---- | --6.6M | --13.94M | ---- | ---- |
| -Accounts receivable | 56.06%363.57M | 27.00%351M | 71.24%303.97M | 43.69%280.68M | 77.30%232.96M | 116.22%276.38M | 39.30%177.51M | 170.92%195.33M | --131.39M | 182.34%127.82M |
| Other receivables (including interest and dividends) | -77.71%241.81K | -2.86%1.96M | -96.13%263.93K | -82.36%1.32M | -65.03%1.08M | -56.58%2.02M | 103.41%6.81M | 48.60%7.5M | --3.1M | 31.13%4.65M |
| -Other receivable | ---- | -2.86%1.96M | ---- | -82.36%1.32M | ---- | -56.58%2.02M | ---- | 48.60%7.5M | ---- | 31.13%4.65M |
| Contractual assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --19.24M | ---- |
| Advance payment | 8.93%56.07M | 46.74%57.29M | 105.30%82.23M | 74.08%64.35M | 6.26%51.47M | 16.35%39.04M | -33.91%40.05M | -29.19%36.97M | --48.44M | -10.59%33.56M |
| Inventories | -17.85%97.07M | -19.75%95.58M | -20.02%93.51M | 8.13%118.38M | 19.45%118.16M | 82.32%119.09M | 142.58%116.91M | 439.94%109.48M | --98.92M | 558.59%65.32M |
| Receivable financing | -96.69%23.76K | ---- | ---- | ---- | --716.85K | --31.26M | ---- | ---- | ---- | ---- |
| Non-current assets due within one year | --53.2M | ---- | ---- | ---- | ---- | ---- | 30.23%323.29M | 30.60%321.58M | --317.86M | 29.54%313.29M |
| Other current assets | 2,103.62%319.19M | 2,925.48%314.35M | 2,288.13%304.79M | 3,871.23%307.17M | 9.40%14.48M | -14.46%10.39M | 54.46%12.76M | -69.94%7.73M | --13.24M | -63.96%12.15M |
| Total current assets | -8.39%7.9B | -10.78%7.82B | -12.04%7.87B | -11.42%8.07B | -6.05%8.62B | -5.75%8.77B | -2.39%8.95B | 42.05%9.11B | --9.18B | 44.92%9.3B |
| Non Current assets | ||||||||||
| Fixed assets | ---- | 9.21%615.87M | ---- | 21.85%574.99M | ---- | 33.01%563.92M | ---- | 25.95%471.89M | ---- | 118.93%423.96M |
| Constru in process | ---- | -16.80%138.86M | ---- | -6.51%198.58M | ---- | -15.55%166.91M | ---- | 74.74%212.41M | ---- | -14.33%197.65M |
| Intangible assets | -2.86%255.97M | -2.97%258.14M | -2.60%259.12M | -2.57%261.17M | -2.63%263.5M | -2.60%266.03M | 0.78%266.04M | 0.68%268.07M | --270.61M | 154.21%273.14M |
| Goodwill | 0.00%3.12M | 0.00%3.12M | 0.00%3.12M | 0.00%3.12M | 0.00%3.12M | 0.00%3.12M | 0.00%3.12M | 0.00%3.12M | --3.12M | 0.00%3.12M |
| Long deferred expense | -3.11%30.41M | -4.07%31.94M | -8.91%33.03M | -8.51%34.4M | -13.65%31.39M | -16.39%33.3M | 186.99%36.26M | 184.30%37.6M | --36.35M | 236.00%39.82M |
| Usufruct assets | -6.80%56.87M | -12.02%59.54M | 43.25%66.5M | 33.03%71.92M | 15.54%61.02M | 13.00%67.68M | -26.08%46.43M | -22.48%54.07M | --52.81M | -25.28%59.89M |
| Other non current assets | 2,067.06%429.12M | 897.66%479.43M | 1,482.64%459.29M | 1,609.99%457.23M | -13.19%19.8M | 143.08%48.06M | -53.79%29.02M | -59.79%26.74M | --22.81M | -55.88%19.77M |
| Total non current assets | 32.35%1.52B | 37.47%1.59B | 45.27%1.59B | 48.18%1.61B | 10.11%1.15B | 12.20%1.15B | -13.65%1.09B | -12.55%1.08B | --1.04B | 3.13%1.03B |
| Total assets | -3.61%9.41B | -5.17%9.41B | -5.80%9.46B | -5.09%9.68B | -4.40%9.77B | -3.96%9.92B | -3.75%10.04B | 33.21%10.19B | 40.50%10.22B | 39.30%10.33B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | --80.06M | --137.45M | 2,021.01%106.05M | ---- | ---- | ---- | --5M | --5M | ---- | ---- |
| Notes payable and accounts payable | 39.57%165.68M | -4.85%128.36M | 25.59%143.07M | -9.42%117.24M | -20.30%118.71M | 13.75%134.9M | 14.40%113.91M | 40.65%129.43M | --148.94M | 40.18%118.6M |
| -Accounts payable | 39.57%165.68M | -4.85%128.36M | 25.59%143.07M | -9.42%117.24M | -20.30%118.71M | 13.75%134.9M | 14.40%113.91M | 40.65%129.43M | --148.94M | 40.18%118.6M |
| Contract liabilities | ---- | ---- | --76.46K | ---- | ---- | ---- | ---- | ---- | ---- | -37.90%4.24M |
| Salaries payable | 25.95%41.17M | 18.21%62.65M | 8.16%56.69M | 9.70%45.78M | -4.53%32.69M | -7.04%53M | 5.99%52.41M | 16.53%41.73M | --34.24M | 37.70%57.01M |
| Taxs payable | 53.25%41.87M | 103.99%31.11M | 16.05%27.72M | 28.75%27.45M | 24.07%27.32M | -53.18%15.25M | -11.02%23.88M | 3.47%21.32M | --22.02M | -12.80%32.58M |
| Other payable (including interest and dividends) | 4.62%106.87M | 1.85%125.41M | 16.27%117.31M | -22.17%119.49M | -26.23%102.15M | -31.00%123.13M | -17.76%100.89M | 32.37%153.53M | --138.47M | 85.53%178.44M |
| -Other payable | ---- | 1.85%125.41M | ---- | -22.17%119.49M | ---- | -31.00%123.13M | ---- | 32.37%153.53M | ---- | 85.53%178.44M |
| Non current liabilities due within one year | 212.78%95.49M | 211.53%87.95M | 340.20%88.87M | 101.72%39.18M | 58.47%30.53M | 40.38%28.23M | 16.27%20.19M | 11.11%19.42M | --19.27M | -1.10%20.11M |
| Other current liabilities | -72.69%476.34M | -72.43%476.34M | -72.09%476.34M | 3.50%1.75B | 4.22%1.74B | 4.27%1.73B | 258.36%1.71B | 64,333.84%1.69B | --1.67B | 5,433.13%1.66B |
| Total current liabilities | -50.98%1.01B | -49.60%1.05B | -49.78%1.02B | 1.84%2.1B | 0.93%2.06B | 0.69%2.08B | 152.11%2.02B | 603.29%2.06B | --2.04B | 552.98%2.07B |
| Current liabilities | ||||||||||
| Long term account payable | ---- | -0.80%303.13M | ---- | -0.81%294.05M | ---- | 6.19%305.58M | ---- | --296.45M | ---- | 663.43%287.76M |
| Long term deferred income | -2.58%270.74M | -6.66%263M | -6.99%267.02M | -7.27%269.64M | -4.00%277.9M | -4.02%281.78M | -2.59%287.1M | -3.37%290.8M | --289.49M | 91.02%293.58M |
| Lease liabilities | -29.32%25.21M | -37.13%27.44M | 35.17%35.27M | 13.13%39.78M | 19.91%35.66M | 23.16%43.65M | -30.82%26.1M | -12.30%35.17M | --29.74M | -25.30%35.44M |
| Total non current liabilities | 149.68%1.64B | 145.29%1.61B | 154.48%1.62B | 1.15%637.37M | 7.46%656.87M | 6.57%657.3M | -65.54%636.37M | -65.76%630.11M | --611.28M | -57.15%616.79M |
| Total liabilities | -2.39%2.65B | -2.84%2.66B | -0.91%2.64B | 1.68%2.74B | 2.44%2.71B | 2.04%2.74B | 0.39%2.66B | 26.20%2.69B | 53.83%2.65B | 52.87%2.68B |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.35%23.4K | 0.36%23.4K | 0.27%23.39K | 0.26%23.32K | 0.58%23.32K | 0.57%23.32K | 0.69%23.33K | 19.52%23.26K | --23.18K | 19.57%23.18K |
| Capital reserve funds | -0.31%12.13B | -0.33%12.11B | -0.16%12.14B | 0.10%12.15B | 0.50%12.17B | 0.57%12.15B | 1.02%12.16B | 25.10%12.14B | --12.11B | 25.43%12.08B |
| Retained profit | -5.37%-5.5B | -8.67%-5.52B | -7.54%-5.35B | -9.67%-5.34B | -17.07%-5.22B | -14.19%-5.08B | -13.28%-4.98B | -21.67%-4.87B | ---4.46B | -24.89%-4.45B |
| Less:Treasury stock | 21.99%9.01M | --3.1M | ---- | --7.39M | --7.39M | ---- | --2.42M | ---- | ---- | ---- |
| Other composite income | 49.82%131.37M | 78.67%137.99M | -90.38%15.91M | -42.46%113.56M | 171.53%87.68M | 312.69%77.23M | 69.77%165.37M | 186.91%197.38M | ---122.58M | 92.20%-36.31M |
| Shareholders equity without minority interests | -3.92%6.75B | -5.91%6.73B | -7.38%6.8B | -7.38%6.91B | -6.63%7.02B | -5.91%7.15B | -5.11%7.34B | 36.42%7.46B | 36.83%7.52B | 35.55%7.6B |
| Minority interests | -42.09%17.14M | -37.20%20.63M | -41.31%22.95M | -33.56%26.75M | -34.81%29.6M | -30.43%32.86M | -14.73%39.1M | -19.32%40.25M | --45.4M | -13.12%47.23M |
| Total shareholder equity | -4.08%6.77B | -6.05%6.75B | -7.56%6.82B | -7.52%6.94B | -6.79%7.05B | -6.06%7.18B | -5.17%7.38B | 35.91%7.5B | 36.37%7.57B | 35.08%7.64B |
| Total liabilityies and equity | -3.61%9.41B | -5.17%9.41B | -5.80%9.46B | -5.09%9.68B | -4.40%9.77B | -3.96%9.92B | -3.75%10.04B | 33.21%10.19B | 40.50%10.22B | 39.30%10.33B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.